Epydiolex approved to treat rare genetic disorder in UK
CBD-based Epydiolex has received approval in the UK as an adjunctive treatment for seizures associated with tuberous sclerosis complex (TSC), the drug’s maker, GW Pharmaceuticals, announced….
CBD-based Epydiolex has received approval in the UK as an adjunctive treatment for seizures associated with tuberous sclerosis complex (TSC), the drug’s maker, GW Pharmaceuticals, announced….
Officials in Zimbabwe say changes that loosened rules for cannabis production have translated into investment interest from the U.S., U.K, Germany and Switzerland, as licensing…
Tomáš Zábranský, who spearheaded efforts that resulted in the legalization of medical cannabis in the Czech Republic and enjoyed wide respect in international medical circles,…
A newly launched UK cannabis body, CanIndCou (CIC), says it will work on behalf of patients while promoting reduction of red tape it says is…
Licensing for cannabinoid clinical research and consumer cannabinoids should move from the UK’s Home Office to two health agencies, according to a report from a…
CBD and medical marijuana can now be produced for export from the Isle of Man after rules were set by the government. Producer candidates can…
The U.S. National Football League (NFL) said it will award $1 million in grants for research into pain management and cannabinoids. The league is soliciting…
Regulated medical cannabis and hemp industries in Argentina could generate 10,000 new jobs, $500 million in domestic sales and $50 million in exports annually, Minister…
A bill that would establish the THC limit for industrial hemp at a full 1.0% and set the stage for the legal marketing of CBD-based…
The Danish government has permanently authorized licensed companies to produce and export medical cannabis independent of an existing pilot program. “This is an important milestone…